Johnson & Johnson’s COVID-19 vaccine could end up being a two-dose regimen if it proves to offer more protection than one, a White House adviser said Thursday.
“Johnson & Johnson is currently evaluating how their vaccine performs with two doses — in other words their own booster,” Andy Slavitt, a senior adviser to the COVID-19 response team, said in an interview on Washington Post Live.
“Pending the results of that, pending what the FDA has to say if the vaccine is approved in the first place, there may be a second shot of Johnson & Johnson.”
The drugmaker announced a large-scale trial to test the two-dose regimen in November.
The company said it planned to enroll as many as 60,000 participants worldwide for the study, which was run parallel with a one-dose trial.
The participants are given either either a placebo or the experimental shot, currently called Ad26COV2, followed by a second dose or placebo 57 days later.
The post Johnson & Johnson vaccine could be two doses: White House adviser appeared first on Daily Truth Report • DailyTruthReport.com.
This content is courtesy of, and owned and copyrighted by, https://dailytruthreport.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.